DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

PODD Insulet Corporation

Healthcare

Price
$134.73
Intrinsic value
$100.04
Buy price
$80.03
Discount
-34.7%
Overvalued

Live signals (2)

Daily bars as of Oct 8, 2026
Conflicting signals
  • DCDowntrend ContinuationBearish ↓

    A strong bearish bar rejecting a falling 20/50-SMA stack - the downtrend resuming after a bounce into the moving averages.

    Fired Oct 7, 20261 daily bar ago32.9% win rate · 0.89x profit factor
  • FS-BullishFailure Swing (bullish)Bullish ↑

    Price undercut a recent swing low and closed back above it - the breakdown failed and trapped the sellers who chased it.

    Fired Oct 2, 20264 daily bars ago37.4% win rate · 1.07x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)25.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$511,200,000.00
Total debt
$948,400,000.00
Cash & STI
$534,900,000.00
Shares out.
69,403,000
Overvalued
Intrinsic value$100.04
Buy price (with MOS)$80.03
Current price$134.73
Discount to intrinsic value-34.7%

7-step quality scorecard

ROE quality
HIGH_VOLATILE
Average ROE
20.0%
Current ROE
16.3%
Minimum ROE
1.0%
Debt quality
MODERATE
Debt / Equity
0.63x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.36x

Technical chart

Confluence: DOWNTREND (0/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
revenueCAGR
Valuation model
DCF_OCF
Debt as % of DCF PV
12.9%
Public economic interest
100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.